tradmap

SANA Earnings Sana Biotechnology, Inc.

Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated

Annual results

Diluted EPS (annual)
-$22 -$11 $0 2020 2021 2022 2023 2024 2025
EPS
Net income (annual)
-$356M -$178M $0 2019 2020 2021 2022 2023 2024 2025
Net income
Return on equity (annual)
-152% -30% 92% 0% 2019 2020 2021 2022 2023 2024 2025
ROE

Quarterly results

Diluted EPS (quarterly)
-$1 -$1 $0 Q3 '22 Q2 '23 Q1 '24 Q3 '24 Q2 '25 Q1 '26
EPS
Net income (quarterly)
-$107M -$53M $984000 $0 Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
Net income
Return on equity (quarterly)
-77% -38% 0% 0% Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
ROE

Reported EPS history

1–23 of 23
Q2 20262026-06-30-0.392026-08-1010-Q
Q1 20262026-03-31-0.172026-05-1110-Q
FY 20252025-12-31-0.962026-03-0310-K
Q3 20252025-09-30-0.752025-11-0610-Q
Q2 20262025-06-30-0.602026-08-1010-Q
Q1 20262025-03-31-0.212026-05-1110-Q
FY 20252024-12-31-1.162026-03-0310-K
Q3 20252024-09-30-0.952025-11-0610-Q
Q2 20252024-06-30-0.702025-08-1110-Q
Q1 20252024-03-31-0.492025-05-0810-Q
FY 20252023-12-31-1.462026-03-0310-K
Q3 20242023-09-30-1.012024-11-0810-Q
Q2 20242023-06-30-1.022024-08-0810-Q
Q1 20242023-03-31-0.432024-05-0810-Q
FY 20242022-12-31-1.432025-03-1710-K
Q3 20232022-09-30-1.012023-11-0810-Q
Q2 20232022-06-30-0.562023-08-0310-Q
Q1 20232022-03-31-0.172023-05-0810-Q
FY 20232021-12-31-2.142024-02-2910-K
Q3 20222021-09-30-1.532022-11-0210-Q
Q2 20222021-06-30-1.082022-08-0410-Q
FY 20222020-12-31-21.922023-03-1610-K
Q2 20212020-06-30-10.472021-08-0410-Q

Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.